Provided by Tiger Fintech (Singapore) Pte. Ltd.

Repro Med Systems, Inc.

3.58
+0.17004.99%
Post-market: 3.580.00000.00%16:21 EDT
Volume:183.60K
Turnover:646.92K
Market Cap:165.18M
PE:-31.00
High:3.64
Open:3.44
Low:3.37
Close:3.41
Loading ...

KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ...

GuruFocus.com
·
13 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Mar

KORU Medical Systems Inc expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
11 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Integer (ITGR) Soars 3.8%: Is Further Upside Left in the Stock?

Zacks
·
06 Mar

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

Business Wire
·
20 Feb

REPRO-MED Systems (KRMD) Gets a Buy from Lake Street

TIPRANKS
·
18 Feb

KORU Medical Systems' Shares Fall After Downgrade From Piper Sandler

MT Newswires Live
·
15 Feb

Piper Sandler Downgrades Koru Medical, Citing Valuation Concerns

GuruFocus.com
·
15 Feb

Piper Sandler Downgrades KORU Medical Systems to Neutral From Overweight, $4.50 Price Target

MT Newswires Live
·
14 Feb

KORU Medical Systems Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
14 Feb

Koru Medical downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
14 Feb

Craig-Hallum Remains a Buy on REPRO-MED Systems (KRMD)

TIPRANKS
·
07 Feb

Lake Street Remains a Buy on REPRO-MED Systems (KRMD)

TIPRANKS
·
07 Feb

CuriosityStream And 2 Other Promising Penny Stocks On US Exchange

Simply Wall St.
·
07 Feb

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

THOMSON REUTERS
·
07 Feb

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

Business Wire
·
07 Feb

Craig-Hallum Sticks to Their Buy Rating for REPRO-MED Systems (KRMD)

TIPRANKS
·
31 Jan

REPRO-MED Systems (KRMD) Gets a Buy from Lake Street

TIPRANKS
·
31 Jan

Koru Partners With Pharmaceutical Firm for Late-Stage Trial of Prospective Kidney Treatment

MT Newswires Live
·
31 Jan